Colombian consensus on vaccination in patients with chronic kidney disease
PDF (Español)


kidney disease
renal dialysis
kidney transplantation

How to Cite

Silva Monsalve E, Roncancio Villamil GE, Forero J, Mesa JG, Cárdenas Aguilera JG, Estévez M, Baquero Rodríguez R, Carrascal M, Beltrán Arroyave CP, Yomayusa González N, Rico Fontalvo J, Aroca G, Chacón Acevedo KR, Camacho Moreno G, López Mora MJ, Garcés Samudio CG, Cortés JA, Gutiérrez Tobar IF, Torres Hernández D, López P, Soler Romeo MJ. Colombian consensus on vaccination in patients with chronic kidney disease. Rev. Colomb. Nefrol. [Internet]. 2022 Dec. 22 [cited 2024 Feb. 26];9(3). Available from:


Introduction: Patients with kidney disease are a highly complex population due to their multimorbidity conditions, cardiovascular risk, and requirement for immunosuppressive therapies. Vaccination is one of the main strategies to mitigate the risk of infections, however, the response to vaccines is affected by the loss of the quality of immune function, an effect that is greater as kidney disease progresses or the use of immunosuppressive drugs is required. Therefore, immunization practices should be encouraged in patients in earlier stages of their disease. Unfortunately, there is a wide lack of knowledge among care providers regarding the best immunization practices, additionally, in Colombia, there is no insurance coverage in the health benefit plan for many of the required vaccines.

Purpose: Generate evidence-informed recommendations on vaccination in patients with kidney disease and related special conditions.

Methodology: Based on a critical review and analysis of the evidence, the developer group formulated recommendations on the indications, contraindications and special considerations for immunization in patients with kidney disease. A group of experts in infectious diseases and nephrology were consulted about their agreement with the proposed recommendations. An agreement threshold of 80% was defined.

Results: Initially, 135 recommendations were formulated, of which 124 were approved in the virtual consultation, those that did not exceed the threshold were agreed upon in a virtual session. At the end of the process, 142 recommendations were obtained.

Conclusions: Vaccination is a highly recommended prevention strategy in patients with kidney disease, with favorable impacts on disease burden and survival. The proposed recommendations are expected to guide and standardize immunization practices in these patients and improve health outcomes for this population.
PDF (Español)


Arias-Murillo YR, Benavides CA, Salinas MA, Osorio-Arango K, Plazas-Sierra C, Cortés JA. SARS-CoV2/COVID-19 infection in transplant recipients and in patients on the organ transplant waiting list in Colombia. Transplant Proc. 2021;53(4):1237-44.

Millán DA, Fajardo-Cediel W, Tobar-Roa V, García-Perdomo HA, Autrán-Gómez AM. Strategies to Mitigate the Impact of COVID 19 Pandemic on Organ Donation and Kidney Transplantation in Latin America. Curr Urol Rep. 2021;22(12):1-7.

Oliver MJ, Thomas D, Balamchi S, Ip J, Naylor K, Dixon SN, et al. Vaccine Effectiveness Against SARS-CoV-2 Infection and Severe Outcomes in the Maintenance Dialysis Population in Ontario, Canada. J Am Soc Nephrol. 2022;33(4):839-49.

Sanders SF, Bemelman FJ, Messchendorp AL, Baan CC, van Baarle D, van Binnendijk R, et al. The RECOVAC immune-response study: the immunogenicity, tolerability, and safety of COVID-19 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplant. Transplant. 2022;106(4):821-34.

Karim F, Chauhan S, Dhar J. Analysing an epidemic-economic model in the presence of novel corona virus infection: capital stabilization, media effect, and the role of vaccine. Eur Phys J Spec Top. 2022;1-18.

Griffin MR, Zhu Y, Moore MR, Whitney CG, Grijalva CG. US hospitalizations for pneumonia after a decade of pneumococcal vaccination. N Engl J Med. 2013;369(2):155-63.

Quitián LM, Rodríguez-Martinez CE, Sossa-Briceño MP, Cortés JA. Disease burden and vaccination priorities in Colombia. Vaccine. 2022;40(12):1717-21.

Luxardo R, Ceretta L, González-Bedat M, Ferreiro A, Rosa-Diez G. The Latin American Dialysis and Renal Transplantation Registry: report 2019. Clin Kidney J. 2022;15(3):425-31.

Ishigami J, Matsushita K. Clinical epidemiology of infectious disease among patients with chronic kidney disease. Clin Exp Nephrol. 2019;23(4):437-47.

Pahl MV, Vaziri ND. Immune function in chronic kidney disease. En: Chronic renal disease. Elsevier; 2020. p. 503-19.

Syed-Ahmed M, Narayanan M. Immune dysfunction and risk of infection in chronic kidney disease. Adv Chronic Kidney Dis. 2019;26(1):8-15.

Papp KA, Haraoui B, Kumar D, Marshall JK, Bissonnette R, Bitton A, et al. Vaccination guidelines for patients with immune-mediated disorders taking immunosuppressive therapies: executive summary. J Rheumatol. 2019;46(7):751-4.

Ma BM, Yap DY, Yip TP, Hung IF, Tang SC, Chan TM. Vaccination in patients with chronic kidney disease-Review of current recommendations and recent advances. Nephrol. 2021;26(1):5-11.

Mathew R, Mason D, Kennedy JS. Vaccination issues in patients with chronic kidney disease. Expert Rev Vaccines. 2014;13(2):285-98.

Krueger KM, Ison MG, Ghossein C. Practical guide to vaccination in all stages of CKD, including patients treated by dialysis or kidney transplantation. Am J kidney Dis. 2020;75(3):417-25.

Camargo LF, Lother AM, Mazzali M, Stucchi RSB. Immunization in end stage renal disease: the perception of waiting list patients. Transpl Infect Dis. 2018;20(3):e12831.

Reddy S, Chitturi C, Yee J. Vaccination in chronic kidney disease. Adv Chronic Kidney Dis. 2019;26(1):72-8.

Sanabria AJ, Rigau D, Rotaeche R, Selva A, Marzo-Castillejo M, Alonso-Coello P. Sistema GRADE: metodología para la realización de recomendaciones para la práctica clínica. Atención Primaria. 2015;47(1):48-55.

Janeway Jr CA, Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002;20(1):197-216.

Delves PJ, Roitt IM. The immune system. N Engl J Med. 2000;343(1):37-49.

Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol. 2008;3(5):1526-33.

Rico-Fontalvo JE, Arnedo RD, Martínez VL, Pájaro N, Franco EA, Calvo CP, et al. Vacunación en pacientes con enfermedad renal crónica. Arch Med. 2021;17(1):6.

Saran R, Robinson B, Abbott KC, Bragg-Gresham J, Chen X, Gipson D, et al. US renal data system 2019 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2020;75(1):A6-7.

Barril G, Teruel JL. Calendario de vacunas en la enfermedad renal crónica avanzada. Nefrol. 2008;28:95-9.

Steiger S, Rossaint J, Zarbock A, Anders HJ. Secondary Immunodeficiency Related to Kidney Disease (SIDKD)-Definition, Unmet Need, and Mechanisms. J Am Soc Nephrol. 2022;33(2):259-78.

Cohen G, Haag-Weber M, Hörl WH. Immune dysfunction in uremia. Kidney Int Suppl. 1997;(62).

Girndt M, Sester M, Sester U, Kaul H, Köhler H. Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect. Kidney Int. 2001;59(4):1382-9.

Ando M, Shibuya A, Tsuchiya K, Akiba T, Nitta K. Reduced expression of Toll-like receptor 4 contributes to impaired cytokine response of monocytes in uremic patients. Kidney Int. 2006;70(2):358-62.

Frasca D, Blomberg BB. B cell function and influenza vaccine responses in healthy aging and disease. Curr Opin Immunol. 2014;29:112-8.

Zheng JQ, Hou YC, Zheng CM, Lu CL, Liu WC, Wu CC, et al. Cholecalciferol additively reduces serum parathyroid hormone and increases vitamin D and cathelicidin levels in paricalcitol-treated secondary hyperparathyroid hemodialysis patients. Nutrients. 2016;8(11):708.

Zitt E, Sprenger-Mähr H, Knoll F, Neyer U, Lhotta K. Vitamin D deficiency is associated with poor response to active hepatitis B immunisation in patients with chronic kidney disease. Vaccine. 2012;30(5):931-5.

Tangpricha V, Wasse H. Vitamin D therapy in kidney disease: more vitamin D is necessary. Am J Kidney Dis. 2014;64(5):667-9.

Kosmadakis G, Albaret J, Correia ED, Somda F, Aguilera D. Vaccination practices in dialysis patients: A narrative review. Semin Dial. 2018;31(5):507-18.

Crépin T, Legendre M, Carron C, Vachey C, Courivaud C, Rebibou JM, et al. Uraemia-induced immune senescence and clinical outcomes in chronic kidney disease patients. Nephrol Dial Transplant. 2020;35(4):624-32.

Ducloux D, Legendre M, Bamoulid J, Saas P, Courivaud C, Crepin T. End-Stage Renal Disease-Related Accelerated Immune Senescence: Is Rejuvenation of the Immune System a Therapeutic Goal? Front Med. 2021;1540.

Crépin T, Legendre M, Courivaud C, Vauchy C, Laheurte C, Rebibou JM, et al. Maladie rénale chronique et immunosénescence prématurée: données et perspectives. Néphrol Thér. 2020;16(1):9-18.

Xiang F, Chen R, Cao X, Shen B, Chen X, Ding X, et al. Premature aging of circulating T cells predicts all-cause mortality in hemodialysis patients. BMC Nephrol. 2020;21(1):1-10.

Beyer WE, Versluis DJ, Kramer P, Diderich PP, Weimar W, Masurel N. Trivalent influenza vaccine in patients on haemodialysis: impaired seroresponse with differences for A-H3N2 and A-H1N1 vaccine components. Vaccine. 1987;5(1):43-8.

Mulley WR, Le ST, Ives KE. Primary seroresponses to double-dose compared with standard-dose hepatitis B vaccination in patients with chronic kidney disease: a systematic review and meta-analysis. Nephrol Dial Transplant. 2017;32(1):136-43.

Yao T, Shao Z, Wu L, Dong S, Gao L, Wu Y, et al. Long-term persistent immunogenicity after successful standard and triple-dosed hepatitis B vaccine in hemodialysis patients: A 3-year follow-up study in China. Vaccine. 2021;39(18):2537-44.

Fabrizi F, Cerutti R, Garcia-Agudo R, Bellincioni C, Porata G, Frontini G, et al. Adjuvanted recombinant HBV vaccine (HBV-AS04) is effective over extended follow-up in dialysis population. An open-label non randomized trial. Clin Res Hepatol Gastroenterol. 2020;44(6):905-12.

Fuchshuber A, Kühnemund O, Keuth B, Lütticken R, Michalk D, Querfeld U. Pneumococcal vaccine in children and young adults with chronic renal disease. Nephrol Dial Transplant. 1996;11(3):468-73.

Meijers RW, Litjens NH, de Wit EA, Langerak AW, Baan CC, Betjes MG. Uremia?associated immunological aging is stably imprinted in the T?cell system and not reversed by kidney transplantation. Transpl Int. 2014;27(12):1272-84.

Bouwmans P, Messchendorp AL, Sanders JS, Hilbrands L, Reinders ME, Vart P, et al. Long-term efficacy and safety of SARS-CoV-2 vaccination in patients with chronic kidney disease, on dialysis or after kidney transplantation: a national prospective observational cohort study. BMC Nephrol. 2022;23(1):1-10.

Benotmane I, Gautier-Vargas G, Cognard N, Olagne J, Heibel F, Braun-Parvez L, et al. Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine. Kidney Int. 2021;99(6):1498-500.

Grupper A, Sharon N, Finn T, Cohen R, Israel M, Agbaria A, et al. Humoral response to the Pfizer BNT162b2 vaccine in patients undergoing maintenance hemodialysis. Clin J Am Soc Nephrol. 2021;16(7):1037-42.

Boyarsky BJ, Werbel WA, Avery RK, Tobian AA, Massie AB, Segev DL, et al. Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients. JAMA. 2021 my.;325(17):1784-6.

Correia AL, Leal R, Pimenta AC, Fernandes M, Marques MG, Rodrigues L, et al. The type of SARS?CoV?2 vaccine influences serological response in kidney transplant recipients. Clin Transplant. 2022;36(4):e14585.

Ronicke S, Osmanodja B, Budde K, Jens A, Hammett C, Koch N, et al. Declining Course of Humoral Immune Response in Initially Responding Kidney Transplant Recipients after Repeated SARS-CoV-2 Vaccination. medRxiv. 2022;11(22):3291.

Sattler A, Schrezenmeier E, Weber UA, Potekhin A, Bachmann F, Straub-Hohenbleicher H, et al. Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients. J Clin Invest. 2021;131(14).

Linardou H, Spanakis N, Koliou GA, Christopoulou A, Karageorgopoulou S, Alevra N, et al. Responses to SARS-CoV-2 Vaccination in Patients with Cancer (ReCOVer Study): A Prospective Cohort Study of the Hellenic Cooperative Oncology Group. Cancers (Basel). 2021 sept.;13(18).

Bitsori M, Galanakis E. Vaccine-preventable infection morbidity of patients with chronic kidney disease and cocoon vaccination strategies. Expert Rev Vaccines. 2015;14(10):1385-95.

Tang K, Wu X, Luo Y, Wei Z, Feng L, Wu L. Meta-analysis of immunologic response after COVID-19 mRNA vaccination in solid organ transplant recipients. J Infect. 2022;84(5):e73-5.

Cruz-Teran C, Tiruthani K, McSweeney M, Ma A, Pickles R, Lai SK. Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy. Adv Drug Deliv Rev. 2021;169:100-17.

Espi M, Charmetant X, Barba T, Mathieu C, Pelletier C, Koppe L, et al. A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysis. Kidney Int. 2022;101(2):390-402.

NHSGGC. Immunisation guideline for children with chronic kidney disease. Paediatrics for Health Professionals [Internet]. 2021. Disponible en:

Bakkalo?lu SA, Özdemir-Atikel Y, Paglialonga F, Stefanidis CJ, Askiti V, Vidal E, et al. Vaccination Practices in Pediatric Dialysis Patients Across Europe. A European Pediatric Dialysis Working Group and European Society for Pediatric Nephrology Dialysis Working Group Study. Nephron. 2018;138(4):280-6.

Asociación Española de Pediatría. Manual de vacunas en línea de la AEP. Comité asesor de vacunas [Internet]. 2021. Disponible en:

Gunawansa N, Rathore R, Sharma A, Halawa A. Vaccination practices in End Stage Renal Failure and Renal Transplantation; Review of current guidelines and recommendations. World J Transplant. 2018;8(3):68-74.

National Health Service. Guidelines for the Promotion of Hepatitis B Vaccination for patients with Chronic Kidney Disease. Indian J Nephrol. 2016;26(supl. 1):S15-8.

Babu TM, Kotton CN. Immunizations in Chronic Kidney Disease and Kidney Transplantation. Curr Treat Options Infect Dis. 2021;13(2):47-65.

Ghungrud D, Sharma R. Awareness on vaccinations among chronic kidney disease patients in rural India. Int J Curr Res Rev. 2020;12(21):56-63.

Ministerio de Salud y Protección Social de Colombia (Minsalud). Lineamientos para la gestión y administración del programa ampliado de inmunizaciones - PAI - 2022 [Internet]. 2022.

Portolés-Pérez J, Marques-Vidas M, Picazo JJ, González-Romo F, García-Rojas A, Pérez-Trallero E, et al. Recomendaciones de vacunación frente a neumococo en enfermos renales en España. Nefrol. 2014;34(5):545-51.

Vandecasteele SJ, Ombelet S, Blumental S, Peetermans WE. The ABC of pneumococcal infections and vaccination in patients with chronic kidney disease. Clin Kidney J. 2015;8(3):318-24.

Tayade A, Ramasubramanian V. Vaccination in CKD patients. Apollo Med. 2013;10(1):29-35.

Center for Disease Control and Prevention (CDC). Vaccines & Immunizations [Internet]. 2021. Disponible en:

BC Centre for Disease Control. Clinical Guidance on COVID- 19 Vaccines for People with Kidney Disease (Dialysis, Non-Dialysis with Advanced Disease, Glomerulonephritis) [Internet]. 2021.

UK Kidney Association. UK Kidney Association guidance on COVID-19 vaccination in highly vulnerable people with kidney disease. 2021.

Ministerio de Salud y Protección Social. Esquema de vacunación de Colombia. Programa Ampliado de Inmunización [Internet]. 2022 [citado 2022 jul 25]. Disponible en:

Salisbury D, Ramsay M, Noakes K. Immunisation against infectious disease - Haemophilus influenzae. En: Greenbook. 2006. p. 126-43.

Center for Disease Control and Prevention (CDC). Pinkbook. Haemophilus Influenzae. [Internet]. 2022 [citado 2022 jul 25]. Disponible en:

American Society Transplantation (AST). COVID-19 Vaccine FAQ Sheet [Internet]. 2022.

Stock PG, Henrich TJ, Segev DL, Werbel WA. Interpreting and addressing suboptimal immune responses after COVID-19 vaccination in solid-organ transplant recipients. J Clin Invest. 2021;131(14).

Baquero-Rodríguez R, Yomayusa N, González C, Yama E, Vargas JG, Rico J, et al. Consenso colombiano de expertos sobre recomendaciones informadas en la evidencia para la prevención, diagnóstico y manejo de la infección por SARS-CoV-2/COVID-19 en paciente pediátrico con enfermedad renal crónica o lesión renal aguda asociada a COVID-19 . Rev Colomb Nefrol .2020;7(supl. 2):50-69.

González C, Yama E, Yomayusa N, Vargas J, Rico J, Ariza A, et al. Colombian consensus of experts on recommendations informed in the evidence for the prevention, diagnosis and management of acute kidney injury by SARS-CoV-2 / COVID-19. Rev Colomb Nefrol. 2020 jun 2;7(supl.2).

Yomayusa N, Yama E, González C, Ariza A, Aroca G, Baquero R, et al. Consenso colombiano de expertos sobre recomendaciones informadas en la evidencia para la prevención, el diagnóstico y el manejo de la infección por SARS-CoV-2/COVID-19 en pacientes con Enfermedad Renal Crónica en diálisis.Rev Colomb Nefrol. 2020;7(supl. 2):119-59.

Center for Disease Control and Prevention (CDC). Human Papillomavirus (HPV). HPV Vaccine Schedule and Dosing [Internet]. 2022.

Nuorti JP, Whitney CG. Prevention of pneumococcal disease among infants and children: use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine. 2010.

García-Sicilia J, Cilleruelo-Ortega MJ. Generalidades de las vacunas. En: Comité Asesor de Vacunas de la Asociación Española de Pediatría (CAV-AEP). Vacunas en Pediatría. Manual de la AEP 2012, 5.ª ed. Madrid: Exlibris ediciones SL; 2012. p. 3-15.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.




Download data is not yet available.